A 10-year analysis of thyrotoxic periodic paralysis in 135 patients: Focus on symptomatology and precipitants

European Journal of Endocrinology

Volumn 169, Issue 5, 2013, Pages 529-536

  Chang, Chin Chun ^a   Cheng, Chih Jen ^a   Sung, Chih Chien ^a   Chiueh, Tzong Shi ^a   Lee, Chien Hsing ^a   Chau, Tom ^b   Lin, Shih Hua ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b PROVIDENCE ST VINCENT MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ADRENALIN; ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; CARBOHYDRATE; CORTICOSTEROID; INSULIN; IODINE 131; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM CHLORIDE;

ACUTE DISEASE; ADOLESCENT; ADULT; ARTICLE; AUTUMN; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE ACTIVITY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG USE; EXERCISE; FAMILY HISTORY; FEMALE; GRAVES DISEASE; HIGH SODIUM INTAKE; HUMAN; HYPERINSULINEMIA; HYPERTHYROIDISM; HYPOKALEMIA; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MUSCLE DISEASE; OBSERVATIONAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PATHOGENESIS; PERIODIC PARALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SUMMER; SYMPTOM; SYMPTOMATOLOGY; TEACHING HOSPITAL; THYROTOXIC PERIODIC PARALYSIS; THYROTOXICOSIS; TOXIC GOITER; UPPER RESPIRATORY TRACT INFECTION;

ADOLESCENT; ADULT; FEMALE; GLUCOSE; HUMANS; HYPERINSULINISM; INSULIN; MALE; MIDDLE AGED; PARALYSIS; PROSPECTIVE STUDIES; SEX FACTORS; THYROID FUNCTION TESTS; THYROID HORMONES; THYROTOXICOSIS; YOUNG ADULT;

EID: 84885126179     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0381     Document Type: Article

References (46)

1. Lin SH, Lin YF & Halperin ML. Hypokalaemia and paralysis. Quarterly Journal of Medicine 2001 94 133-139. (doi:10.1093/qjmed/94.3.133)
2. Lin SH, Lin YF, Chen DT, Chu P, Hsu CW & Halperin ML. Laboratory tests to determine the cause of hypokalemia and paralysis. Archives of Internal Medicine 2004 164 1561-1566. (doi:10.1001/archinte.164.14.1561)
3. Lin SH. Thyrotoxic periodic paralysis. Mayo Clinic Proceedings 2005 80 99-105.
4. Magsino CH Jr & Ryan AJ Jr. Thyrotoxic periodic paralysis. Southern Medical Journal 2000 93 996-1003.
5. Tran HA, Kay SE, Kende M, Doery JC, Colman PG & Read A. Thyrotoxic, hypokalaemic periodic paralysis in Australasian men. Internal Medicine Journal 2003 33 91-94. (doi:10.1046/j.1445-5994.2003.00347.x)
6. Kilpatrick RE, Seiler-Smith S & Levine SN. Thyrotoxic hypokalemic periodic paralysis: reports of four cases in black American males. Thyroid 1994 4 441-445. (doi:10.1089/thy 1994.4.441)
7. Kung AW. Clinical review: thyrotoxic periodic paralysis: a diagnostic challenge. Journal of Clinical Endocrinology and Metabolism 2006 91 2490-2495. (doi:10.1210/jc.2006-0356)
8. Fisher J. Thyrotoxic periodic paralysis with ventricular fibrillation. Archives of Internal Medicine 1982 142 1362-1364. (doi:10.1001/archinte.1982. 00340200130024)
9. Liu YC, Tsai WS, Chau T & Lin SH. Acute hypercapnic respiratory failure due to thyrotoxic periodic paralysis. American Journal of Medical Sciences 2004 327 264-267. (doi:10.1097/00000441-200405000-00025)
10. Hsu YJ, Lin YF, Chau T, Liou JT, Kuo SW & Lin SH. Electrocardiographic manifestations in patients with thyrotoxic periodic paralysis. American Journal of Medical Sciences 2003 326 128-132. (doi:10.1097/00000441-200309000-00004)
11. Lin YF, Wu CC, Pei D, Chu SJ & Lin SH. Diagnosing thyrotoxic periodic paralysis in the ED. American Journal of Emergency Medicine 2003 21 339-342. (doi:10.1016/S0735-6757 (03) 00037-8)
12. Lin SH, Chu P, Cheng CJ, Chu SJ, Hung YJ & Lin YF. Early diagnosis of thyrotoxic periodic paralysis: spot urine calcium to phosphate ratio. Critical Care Medicine 2006 34 2984-2989. (doi:10.1097/01. CCM.0000195013.47004. A8)
13. Shiang JC, Cheng CJ, Tsai MK, Hung YJ, Hsu YJ, Yang SS, Chu SJ & Lin SH. Therapeutic analysis in Chinese patients with thyrotoxic periodic paralysis over 6 years. European Journal of Endocrinology 2009 161 911-916. (doi:10.1530/EJE-09-0553)
14. Ober KP. Thyrotoxic periodic paralysis in the United States: report of 7 cases and review of the literature. Medicine 1992 71 109-120. (doi:10.1097/00005792-199205000-00001)
15. Kelley DE, Gharib H, Kennedy FP, Duda RJ Jr & McManis PG. Thyrotoxic periodic paralysis: report of 10 cases and review of electromyographic findings. Archives of Internal Medicine 1989 149 2597-2600. (doi:10.1001/archinte.1989. 00390110139031)
16. Goh SH. Thyrotoxic periodic paralysis: reports of seven patients presenting with weakness in an Asian emergency department. Emergency Medicine Journal 2002 19 78-79. (doi:10.1136/emj. 19.1.78)
17. Lee KO, Taylor EA, Oh VM, Cheah JS & Aw SE. Hyperinsulinaemia in thyrotoxic hypokalaemic periodic paralysis. Lancet 1991 337 1063-1064. (doi:10.1016/0140-6736 (91) 91710-C)
18. Chan A, Shinde R, Chow CC, Cockram CS & Swaminathan R. Hyperinsulinaemia and Na+, K+-ATPase activity in thyrotoxic periodic paralysis. Clinical Endocrinology 1994 41 213-216. (doi:10.1111/j.1365-2265.1994.tb02532.x)
19. Li W, Changsheng C, Jiangfang F, Bin G, Nanyan Z, Xiaomiao L, Deqiang L, Ying X, Wensong Z & Qiuhe J. Effects of sex steroid hormones, thyroid hormone levels, and insulin regulation on thyrotoxic periodic paralysis in Chinese men. Endocrine 2010 38 386-390. (doi:10.1007/s12020-010-9396-3)
20. Crooks J, Murray I P C & Wayne EJ. Statistical methods applied to the clinical diagnosis of thyrotoxicosis. Quarterly Journal of Medicine 1959 28 211-234.
21. Pat KT Hyperthyroidism. BMJ 1972 2 337-341. (doi:10.1136/bmj.2.5809.337)
22. McFadzean AJ & Yeung R. Periodic paralysis complicating thyrotoxicosis in Chinese. BMJ 1967 1 451-455. (doi:10.1136/bmj.1.5538.451)
23. Liu Z, Braverman LE & Malabanan A. Thyrotoxic periodic paralysis in a Hispanic man after the administration of prednisone. Endocrine Practice 2006 12 427-431. (doi:10.4158/EP12.4.42 7)
24. Hsieh MJ, Lyu RK, Chang WN, Chang KH, Chen CM, Chang HS, Wu YR, Chen ST & Ro LS. Hypokalemic thyrotoxic periodic paralysis: clinical characteristics and predictors of recurrent paralytic attacks. European Journal of Neurology 2008 15 559-564. (doi:10.1111/j.1468-1331.2008.02132.x)
25. Goldberg AP, Sherrard DJ, Haas LB & Brunzell JD. Effect of high carbohydrate feeding with dextrose or sucrose on adipose tissue lipoprotein lipase activity and plasma triglyceride levels in hemodialysis patients. American Journal of Clinical Nutrition 1979 32 1628-1635.
26. He FJ, Markandu ND, Sagnella GA & MacGregor GA. Effect of salt intake on renal excretion of water in humans. Hypertension 2001 38 317-320. (doi:10.1161/01. HYP.38.3.317)
27. Doar JW, Stamp TC, Wynn V & Audhya TK. Effects of oral and intravenous glucose loading in thyrotoxicosis. Studies of plasma glucose, free fatty acid, plasma insulin and blood pyruvate levels. Diabetes 1969 18 633-639.
28. Guerra M, Rodriguez del Castillo A, Battaner E & Mas M. Androgens stimulate preoptic area Na+, K+-ATPase activity in male rats. Neuroscience Letters 1987 78 97-100. (doi:10.1016/0304-3940 (87) 90568-4)
29. Biering H, Bauditz J, Pirlich M, Lochs H & Gerl H. Manifestation of thyrotoxic periodic paralysis in two patients with adrenal adenomas and hyperandrogenaemia. Hormone Research 2003 59 301-304. (doi:10.1159/000070630)
30. Maughan RJ, Watson JS & Weir J. Strength and cross-sectional area of human skeletal muscle. Journal of Physiology 1983 338 3 7-49.
31. Johansson G. Sex differences in the catecholamine output of children. Acta Physiologica Scandinavica 1972 85 569-572. (doi:10.1111/j.1748-1716.1971. tb05295.x)
32. Frankenhaeuser M, Dunne E & Lundberg U. Sex differences in sympathetic-adrenal medullary reactions induced by different stressors. Psychopharmacology 1976 47 1-5. (doi:10.1007/BF00428693)
33. Yao Y, Fan L, Zhang X, Xiao Z, Long Y & Tian H. Episodes of paralysis in Chinese men with thyrotoxic periodic paralysis are associated with elevated serum testosterone. Thyroid 2013 23 420-427. (doi:10.1089/thy.2011.0493)
34. Okinaka S, Shizume K, Iino S, Watanabe A, Irie M, Noguchi A, Kuma S, Kuma K & Ito T The association of periodic paralysis and hyperthyroidism in Japan. Journal of Clinical Endocrinology and Metabolism 1957 17 1454-1459. (doi:10.1210/jcem-17-12-1454)
35. Schöll C, Becker C, Prank K, von zur Mühlen A & Brabant G. Twenty-four-hour rhythms of plasma catecholamines and their relation to cardiovascular parameters in healthy young men. European Journal of Endocrinology 1997 137 675-683. (doi:10.1530/eje.0.1370675)
36. Shishiba Y, Shimizu T, Saito T & Shizume K. Elevated immunoreactive insulin concentration during spontaneous attacks in thyrotoxic periodic paralysis. Metabolism 1972 21 285-290. (doi:10.1016/0026-0495 (72) 90071-6)
37. Jackman RL & Jones RE. Hyperthyroidism and periodic paralysis. Archives of Internal Medicine 1964 113 657-664. (doi:10.1001/archinte.1964. 00280110037007)
38. Shishiba Y, Shizume K, Sakuma M, Yamauchi H, Nakao K & Okinaka S. Studies on electrolyte metabolism in idiopathic and thyrotoxic periodic paralysis. 3. Intra-and extracellular concentrations of potassium and sodium in muscle and their changes during induced attacks of paralysis. Metabolism 1966 15 153-162. (doi:10.1016/0026-0495 (66) 90037-0)
39. Ruff RL. Insulin acts in hypokalemic periodic paralysis by reducing inward rectifier K+ current. Neurology 1999 53 1556-1563. (doi:10.1212/WNL.53.7. 1556)
40. Ryan DP, da Silva MR, Soong TW, Fontaine B, Donaldson MR, Kung W, Jongjaroenprasert W, Liang MC, Khoo DH, Cheah JS et al. Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. Cell 2010 240 88-98. (doi:10.1016/j.cell.2009.12.024)
41. Cheng CJ, Lin SH, Lo YF, Yang SS, Hsu YJ, Cannon SC & Huang CL. Identification and functional characterization of Kir2.6 mutations associated with non-familial hypokalemic periodic paralysis. Journal of Biological Chemistry 2011 286 27425-27435. (doi:10.1074/jbc. M111.249656)
42. Maciel RM, Lindsey SC & Dias da Silva MR. Novel etiopathophy- siological aspects of thyrotoxic periodic paralysis. Nature Reviews. Endocrinology 2011 7 657-667. (doi:10.1038/nrendo.2011.58)
43. Cheung CL, Lau KS, Ho AY, Lee KK, Tiu SC, Lau EY, Leung J, Tsang MW, Chan KW, Yeung CY et al. Genome-wide association study identifies a susceptibility locus for thyrotoxic periodic paralysis at 17q24.3. Nature Genetics 2012 44 1026-1029. (doi:10.1038/ng.2367)
44. Jongjaroenprasert W, Phusantisampan T, Mahasirimongkol S, Mushiroda T, Hirankarn N, Snabboon T, Chanprasertyotin S, Tantiwong P, Soonthornpun S, Rattanapichart P et al. A genome-wide association study identifies novel susceptibility genetic variation for thyrotoxic hypokalemic periodic paralysis. Journal of Human Genetics 2012 57 301-304. (doi:10.1038/jhg. 2012.20)
45. Chu PY, Cheng CJ, Tseng MH, Yang SS, Chen HC & Lin SH. Genetic variant rs623011 (17q24.3) associates with non-familial thyrotoxic and sporadic hypokaIemic paraIysis. Clinica Chimica Acta 2012 414 105-108. (doi:10.1016/j.cca.2012.08.004)
46. Lin SH & Huang CL. Mechanism of thyrotoxic periodic paraIysis. Journal of the American Society of Nephrology 2012 23 985-988. (doi:10.1681/ASN.2012010046)